At Hudson Institute, we value partnerships as a way to progress our research discoveries to the clinic and the community.

Our translational success has been the result of strong partnerships with industry and academia, including collaborative R&D, start-up incubation, and nurturing longer term relationships with biotechnology partners.

We have a number of opportunities available for collaboration, investment, and licensing.

Explore our current pipeline and selected opportunities on our Partnership opportunities page.

Our Business Development Office team works closely with our scientists, collaborators, and with the pharmaceutical and biotechnology sector to take Hudson research discoveries closer to the clinic.

They look after all aspects of commercialisation and commercial contracts, from evaluating invention disclosures to legally capturing intellectual property through negotiation and managing commercial agreements.

Building on over 75 years’ experience in research discoveries, Hudson Institute researchers are world-leaders in their fields. As part of this experience, our scientists have developed unique tools and novel models to further scientific knowledge and provide insight into complex questions about human disease.

Research tools, reagents and models developed at Hudson Institute are available for use, contract research, or licensing. The availability of these research tools and reagents is constantly being updated, so please contact us at commercialisation@hudson.org.au with your specific interests.

Select reagents developed at Hudson Institute, including antibodies, cell lines, and models, are also available through our partnership with the reagent technology transfer service, Ximbo.

Hudson Institute has a strong culture of collaboration and innovation.

We offer the opportunity to engage in collaborative research and development projects. We can also provide contract research opportunities, enabling access to our world-class scientific and technical expertise, facilities, and infrastructure. Contact us at commercialisation@hudson.org.au if you are interested in working with us, or want to learn more about our capabilities.

Hudson Institute of Medical Research is registered as a Research Service Provider (RSP) (RSP no. 115463).

To find out more about the research expertise available at Hudson Institute, read about our Research Centres and Technology platforms and capabilities or explore our areas of research focus.

An integrated network of Technology platforms and capabilities underpins the vibrant research undertaken at Hudson Institute with our local, national and international partners and collaborators. Capabilities include cell therapies and regenerative medicine, flow cytometry, histology, medical genomics, micro imaging, and proteomics.

Located in our Translational Research Facility, a purpose-built research space designed to foster innovation and health translation, our Technology Platforms are uniquely positioned to support our pipeline from discovery through to clinical trial and commercial engagement.

Access is available through collaboration or a fee-for-service model.